DECITABINE Side Effects

7009174-X | Angina Unstable, Chronic Obstructive Pulmonary Disease, Gastrointestinal Haemorrhage
on Sep 14, 2010 Male patient from UNITED STATES , weighting 189.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: angina unstable, chronic obstructive pulmonary disease, gastrointestinal haemorrhage. Decitabine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6698571-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Patient was taking Decitabine (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased on Apr 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 164.2 lb, was diagnosed with colorectal cancer (What is colorectal cancer?) and. Decitabine dosage: . During the same period patient was treated with PANITUMUMAB (View Panitumumab Review and Panitumumab Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), PROTONIX (View Protonix Review and Protonix Label ), MAXALT (View Maxalt Review and Maxalt Label ), DARVOCET (View Darvocet Review and Darvocet Label ).

6685810-2 | Bone Pain, Clostridial Infection, Dehydration, Febrile Neutropenia, Fungal Infection, Hyponatraemia, Mental Status Changes, Muscle Spasms
Adverse event was reported on Apr 07, 2010 by a Male patient taking Decitabine (View Usage) (Dosage: ) was diagnosed with acute myeloid leukaemia, infection prophylaxis and. Location: UNITED STATES , 69 years of age, After Decitabine was administered, patient had the following side effects: bone pain, clostridial infection, dehydration, febrile neutropenia, fungal infection (What is fungal infection?), hyponatraemia, mental status changes, muscle spasms. During the same period patient was treated with VORINOSTAT (View Vorinostat Review and Vorinostat Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6641960-8 | Bone Pain, Clostridial Infection, Dehydration, Febrile Neutropenia, Fungal Infection, Hyponatraemia, Mental Status Changes, Muscle Spasms
on Dec 18, 2009 Male patient from UNITED STATES , 69 years of age, was diagnosed with acute myeloid leukaemia, infection prophylaxis and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, clostridial infection, dehydration, febrile neutropenia, fungal infection (What is fungal infection?), hyponatraemia, mental status changes, muscle spasms. Decitabine dosage: . During the same period patient was treated with VORINOSTAT (View Vorinostat Review and Vorinostat Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.


6641634-3 | Dehydration, Dysphagia, Haemoglobin Decreased, Mucosal Inflammation, Platelet Count Decreased, Presyncope
on Mar 17, 2010 Male patient from UNITED STATES , weighting 170.6 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine (View Usage). Patient had the following side effects: dehydration, dysphagia, haemoglobin decreased, mucosal inflammation, platelet count decreased, presyncope. Decitabine dosage: Decitabine20mg/m2 Day 1-5 Iv Q 4 Weeks. During the same period patient was treated with CYTARABINE (Cytarabine20mg/m2 Day 1-5 Iv Q 4 Weeks) (View Cytarabine Review and Cytarabine Label ), NEUPOGEN (G-csf 5mcg/kg Day 1-5 Sc Q 4 Weeks) (View Neupogen Review and Neupogen Label ). Patient was hospitalized.

6493343-1 | Pyrexia
Patient was taking Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: pyrexia on Dec 11, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with acute myeloid leukaemia and. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.2 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6486800-5 | Acute Respiratory Failure, Anaemia, Cardiac Failure Congestive, Disease Progression, Hyperkalaemia, Refusal Of Treatment By Patient, Renal Failure Acute, Tachypnoea
Adverse event was reported on Dec 09, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 42 Mg Q28days X 5days Iv 20mg/m2) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , 67 years of age, weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: acute respiratory failure, anaemia, cardiac failure congestive, disease progression, hyperkalaemia, refusal of treatment by patient, renal failure acute, tachypnoea. During the same period patient was treated with CYTARABINE (42mg Q28days X 5days Iv 20mg/m2) (View Cytarabine Review and Cytarabine Label ), NEUPOGEN (5 Mcg/kg) (View Neupogen Review and Neupogen Label ).

6476648-X | Back Pain, Bacteraemia, Disease Progression
on Dec 03, 2009 Male patient from UNITED STATES , weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient had the following side effects: back pain (What is back pain?), bacteraemia, disease progression. Decitabine dosage: 20mg/m3, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6476646-6 | Disease Progression, Dyspnoea, Septic Shock
on Dec 03, 2009 Female patient from UNITED STATES , weighting 138.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: disease progression, dyspnoea, septic shock. Decitabine dosage: 20mg/m3 D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6469339-2 | Atrial Fibrillation, Hypoxia, Pneumonia
Patient was taking Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), hypoxia, pneumonia (What is pneumonia?) on Dec 02, 2009 from UNITED STATES Additional patient health information: Male patient , 73 years of age, weighting 253.5 lb, was diagnosed with acute myeloid leukaemia and. Decitabine dosage: 20mg/m2, Di-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6456681-4 | Abdominal Pain, Fatigue, Infection, Pneumonia
Adverse event was reported on Nov 24, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 20 Mg/m2, D1-5 Iv) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 73 years of age, weighting 253.5 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), fatigue, infection (What is infection?), pneumonia (What is pneumonia?). During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg D1-5 Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg. D 1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6448512-3 | Bacterial Infection, Cellulitis, Culture Positive, Hypotension, Pneumonia, Tachycardia
on Nov 19, 2009 Male patient from UNITED STATES , weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: bacterial infection (What is bacterial infection?), cellulitis (What is cellulitis?), culture positive, hypotension, pneumonia (What is pneumonia?), tachycardia. Decitabine dosage: 10mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-4, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6441813-4 | Abdominal Pain, Fatigue, Pyrexia
on Nov 13, 2009 Male patient from UNITED STATES , weighting 253.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), fatigue, pyrexia. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6441789-X | Back Pain, Pneumonia
Patient was taking Decitabine (View Usage). Patient had the following side effects: back pain (What is back pain?), pneumonia (What is pneumonia?) on Nov 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 200.6 lb, was diagnosed with acute myeloid leukaemia and. Decitabine dosage: 20mg/m2, D1-5, Iv Cycle 2. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6438843-5 | Pleural Effusion, Pneumonia
Adverse event was reported on Nov 11, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 20mg/m2, D1-5, Iv) was diagnosed with myeloid leukaemia and. Location: UNITED STATES , weighting 200.6 lb, After Decitabine was administered, patient had the following side effects: pleural effusion, pneumonia (What is pneumonia?). During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5 Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6422024-5 | Electrocardiogram Qt Prolonged, Hypotension, Pneumonia, Respiratory Alkalosis
on Oct 29, 2009 Female patient from UNITED STATES , weighting 172.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, hypotension, pneumonia (What is pneumonia?), respiratory alkalosis. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6417236-0 | Chills, Headache, Pyrexia
on Oct 27, 2009 Male patient from UNITED STATES , 73 years of age, weighting 174.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient had the following side effects: chills, headache (What is headache?), pyrexia. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.2 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6415287-3 | Cough, Dyspnoea, Pneumonia
Patient was taking Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: cough, dyspnoea, pneumonia (What is pneumonia?) on Oct 26, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 172.0 lb, was diagnosed with acute myeloid leukaemia and. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.3 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6312084-4 | Dizziness, Haemorrhage Intracranial, Subdural Haemorrhage, Thrombocytopenia
Adverse event was reported on Aug 13, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 36 Mg Iv) was diagnosed with acute leukaemia, myelodysplastic syndrome and. Location: UNITED STATES , 85 years of age, weighting 167.1 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), haemorrhage intracranial, subdural haemorrhage, thrombocytopenia.

6216134-5 | Bacteria Blood Identified, Fatigue, Fungal Infection, Liver Function Test Abnormal, Pyrexia
on Jun 03, 2009 Female patient from UNITED STATES , weighting 151.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient had the following side effects: bacteria blood identified, fatigue, fungal infection (What is fungal infection?), liver function test abnormal, pyrexia. Decitabine dosage: 20mg/m2 Qd D1-5. During the same period patient was treated with ARSENIC TRIOXIDE (0.2 Mg/m2 Qd D1-5, Then Qw) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg Qd D1-5, Then Qw) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6197038-3 | Dyspnoea, Mouth Ulceration, Mucosal Inflammation, Vaginal Infection
on May 18, 2009 Female patient from UNITED STATES , weighting 170.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: dyspnoea, mouth ulceration, mucosal inflammation, vaginal infection. Decitabine dosage: 20mg/m2 Qd D1-5. During the same period patient was treated with ARSENIC TRIOXIDE (0.2mg/m2 Qd D1-5, Then Qw) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg Qd D1-5, Then Qw) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6156695-8 | Haematemesis, Haemoglobin Decreased, Melaena
Patient was taking Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: haematemesis, haemoglobin decreased, melaena on Apr 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and. Decitabine dosage: 200mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.1 Mg/kg D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw.iv) (View Ascorbic Acid Review and Ascorbic Acid Label ), LYRICA (View Lyrica Review and Lyrica Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZETIA (View Zetia Review and Zetia Label ), FLOMAX (View Flomax Review and Flomax Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6156694-6 | Pleural Effusion, Pyrexia
Adverse event was reported on Apr 13, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 20mg/miv D1-5) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 68 years of age, weighting 200.4 lb, Patient had the following side effects: pleural effusion, pyrexia. During the same period patient was treated with ARSENIC TRIOXIDE (0.2 Mg M2 Iv, D1-5, Then Qw) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg Iv, D1-5, Then Qw) (View Ascorbic Acid Review and Ascorbic Acid Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COLACE (View Colace Review and Colace Label ). Patient was hospitalized.

6155846-9 | Decreased Appetite, Fatigue, Pyrexia
on Apr 13, 2009 Male patient from UNITED STATES , weighting 229.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: decreased appetite, fatigue, pyrexia. Decitabine dosage: 20mg/m2 Qw Iv Cycle 3. During the same period patient was treated with ARSENIC TRIOXIDE (10.4mg Qw Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg Qw Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

6155844-5 | Aeromona Infection, Blood Culture Positive, Chills, Nausea, Neutrophil Count Decreased, Pyrexia
on Apr 13, 2009 Male patient from UNITED STATES , weighting 235.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: aeromona infection, blood culture positive, chills, nausea (What is nausea?), neutrophil count decreased, pyrexia. Decitabine dosage: 20mg/m2 Qd Days 1-5 Cycle 1 Day 1. During the same period patient was treated with ARSENIC TRIOXIDE (0.1 Mg/kg Qd Days 1-5, 8, 15, 22) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (100 Mg Qd Days 1-5, 8, 15, 22) (View Ascorbic Acid Review and Ascorbic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ), PAXIL (View Paxil Review and Paxil Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6155843-3 | Chills, Nausea, Neutrophil Count Decreased, Pyrexia
Patient was taking Decitabine (View Usage). Patient had the following side effects: chills, nausea (What is nausea?), neutrophil count decreased, pyrexia on Apr 13, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 235.0 lb, was diagnosed with myelodysplastic syndrome and. Decitabine dosage: 20mg/m2 Qd Days 1-5 Cycle 1 Day 1. During the same period patient was treated with ARSENIC TRIOXIDE (0.1 Mg/kg Qd Days 1-5, 8, 15, 22) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (100 Mg Qd Days 1-5, 8, 15, 22) (View Ascorbic Acid Review and Ascorbic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ), PAXIL (View Paxil Review and Paxil Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6155841-X | Anaphylactic Transfusion Reaction
Adverse event was reported on Apr 13, 2009 by a Male patient taking Decitabine (View Usage) (Dosage: 20mg/m2 Qd Days 1-5 Cycle 1 Day 1) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 235.0 lb, After Decitabine was administered, patient had the following side effects: anaphylactic transfusion reaction. During the same period patient was treated with ARSENIC TRIOXIDE (0.1 Mg/kg Qd Days 1-5, 8, 15, 22) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (100 Mg Qd Days 1-5, 8, 15, 22) (View Ascorbic Acid Review and Ascorbic Acid Label ), NEXIUM (View Nexium Review and Nexium Label ), PAXIL (View Paxil Review and Paxil Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

6064023-1 | Asthenia, Malaise, Nausea
on Feb 03, 2009 Male patient from UNITED STATES , 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, malaise, nausea (What is nausea?). Decitabine dosage: 28 Mg Every Day Iv. Patient was hospitalized.

6059454-X | Anaemia
on Jan 27, 2009 Male patient from UNITED STATES , 71 years of age, was treated with Decitabine (View Usage). Patient had the following side effects: anaemia. Decitabine dosage: . Patient was hospitalized.

6030049-7 | Haematemesis, Haemoglobin Decreased, Melaena
Patient was taking Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: haematemesis, haemoglobin decreased, melaena on Jan 05, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 149.9 lb, was diagnosed with myelodysplastic syndrome and. Decitabine dosage: 20mg/m2, D1-5, Iv. During the same period patient was treated with ARSENIC TRIOXIDE (0.1 Mg/kg, D1-5, Qw, Iv) (View Arsenic Trioxide Review and Arsenic Trioxide Label ), ASCORBIC ACID (1000 Mg, D1-5, Qw, Iv) (View Ascorbic Acid Review and Ascorbic Acid Label ), LYRICA (View Lyrica Review and Lyrica Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ZETIA (View Zetia Review and Zetia Label ), FLOMAX (View Flomax Review and Flomax Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5800550-7 | Neutropenia, Phlebitis, Pyrexia, Thrombosis, Vasculitis
Adverse event was reported on Jun 20, 2008 by a Female patient taking Decitabine (View Usage) (Dosage: 31.2 Mg, In 1 Day, Intravenous; 31.2 Mg, In 1 Day, Intravenous; 31.8 Mg, In 1 Day, Intravenous) was diagnosed with acute myeloid leukaemia and. Location: TAIWAN, PROVINCE OF CHINA , 67 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: neutropenia, phlebitis, pyrexia, thrombosis, vasculitis (What is vasculitis?). During the same period patient was treated with SENNA (View Senna Review and Senna Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), GLYCYRRHIZA (View Glycyrrhiza Review and Glycyrrhiza Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5509780-5 | Haemorrhage, Leukopenia, Thrombocytopenia
on Nov 07, 2007 Male patient from UNITED STATES , 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine (View Usage). Patient had the following side effects: haemorrhage, leukopenia, thrombocytopenia. Decitabine dosage: 38mg Other Iv. Patient was hospitalized.

5400223-9 | Anaemia, Condition Aggravated, Febrile Neutropenia, Myelodysplastic Syndrome, Thrombocytopenia
on Jul 27, 2007 Male patient from UNITED STATES , 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: anaemia, condition aggravated, febrile neutropenia, myelodysplastic syndrome, thrombocytopenia. Decitabine dosage: 49mg Other Iv. Patient was hospitalized.

5345134-2 | Arthralgia, Burning Sensation, Gait Disturbance, Hyperaesthesia, Hypoaesthesia, Joint Swelling, Muscular Weakness, Musculoskeletal Pain, Neuralgia
Patient was taking Decitabine (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, burning sensation, gait disturbance, hyperaesthesia, hypoaesthesia, joint swelling, muscular weakness, musculoskeletal pain, neuralgia on May 16, 2007 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 160.0 lb, was diagnosed with myelodysplastic syndrome and. Decitabine dosage: See Image. During the same period patient was treated with MSIR (View Msir Review and Msir Label ), SENOKOT (View Senokot Review and Senokot Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5256975-4 | Febrile Neutropenia, Interstitial Lung Disease
Adverse event was reported on Mar 05, 2007 by a Male patient taking Decitabine (View Usage) (Dosage: 20mg/m2 Daily Iv) was diagnosed with acute myeloid leukaemia and. Location: UNITED STATES , 78 years of age, weighting 225.0 lb, Patient had the following side effects: febrile neutropenia, interstitial lung disease. Patient was hospitalized.

5175313-9 | Neutropenia
on Dec 12, 2006 Male patient from UNITED STATES , 75 years of age, weighting 144.4 lb, was treated with Decitabine (View Usage). After Decitabine was administered, patient had the following side effects: neutropenia. Decitabine dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ONDANSETRON HCL (View Ondansetron Hcl Review and Ondansetron Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FILGRASTIM (View Filgrastim Review and Filgrastim Label ). Patient was hospitalized.